Immunity-Driven Cancer Treatment

We're Developing a Groundbreaking Approach to Treat Solid Tumours Using Innovative Immunotherapy

Harnessing the Immune System to Fight Cancer

Selvax’s intratumourally administered co-therapy treatment harnesses the immune system to eradicate tumours and prevent recurrence.

Tested successfully in animals, our approach shows compelling results against eight solid tumour types, without the toxic side effects of chemotherapy.

Efficacy

Tumour Cure Rates in Animals

Tumour regression observed across eight solid tumour types.

Colon Cancer93%

Pancreatic Cancer85.3%

Mesothelioma85.1%

Osteosarcoma80%

Breast Cancer40%

Melanoma37.5%

Kidney Cancer22%

Lung Cancer22%

Scientific Publications

Developing a translational murine-to-canine pathway for an IL-2/agonist anti-CD40 antibody cancer immunotherapy

Proksch SF, et al. 2022.
Veterinary and Comparative Oncology. DOI.

Turning the tumor microenvironment into a self vaccine site

Nelson D. 2012.
OncoImmunology. 1:6, 989-991.

The "Trojan Horse" approach to tumor immunotherapy: targeting the tumor microenvironment

Nelson D, Fisher S, Robinson B. 2014.
Journal of Immunology Research. 2014: 789069.